This information was published on 2025-05-07T00:06:53 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2510029 (IR 1776499) |
| (220) |
06 Dec 2024
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Biochemical and chemical preparations for medical use; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders. |
| (540) | DUVYZAT |
| (550) | Word |
| (730) |
ITALFARMACO S.P.A.
|
| (750) |
AJ Park
|
Find out more about publications on the About page.